Specificity of serine proteinase/serpin complex binding to very-low-density lipoprotein receptor and alpha2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein

Eur J Biochem. 1997 Sep 1;248(2):270-81. doi: 10.1111/j.1432-1033.1997.00270.x.

Abstract

Very-low-density lipoprotein receptor (VLDLR) and alpha2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein (alpha2MR/LRP) are multifunctional endocytosis receptors of the low-density lipoprotein receptor family. Both have been shown to mediate endocytosis and degradation of complex between plasminogen activators and type-1 plasminogen-activator inhibitor (PAI-1) by cultured cells. We have now studied the specificity of binding and endocytosis by VLDLR and alpha2MR/LRP among a variety of serine proteinase/serpin complexes, including various combinations of the serine proteinases urokinase-type and tissue-type plasminogen activators, plasmin, thrombin, human leukocyte elastase, cathepsin G, and plasma kallikrein with the serpins PAI-1, horse leukocyte elastase inhibitor, protein C inhibitor, C1-inhibitor, alpha2-antiplasmin, alpha1-proteinase inhibitor, alpha1-antichymotrypsin, protease nexin-1, heparin cofactor II, and antithrombin III. Binding was estimated with radiolabelled ligands in ligand blotting analysis and microtiter well assays. Endocytosis was estimated by measuring receptor-associated protein (RAP)-sensitive degradation of radiolabelled complexes by Chinese hamster ovary cells transfected with VLDLR cDNA and by COS-1 cells, which have a high endogenous expression of alpha2MR/LRP. We found that the receptors bind with high affinity to some, but not all, combinations of plasminogen activators and thrombin with PAI-1, protease nexin-1, protein C inhibitor, and antithrombin III, while complexes of many serine proteinases with their primary inhibitor, i.e. plasmin/alpha2-antiplasmin complex, do not bind, or bind with a very low affinity. Both the serine proteinase and the serpin moieties contribute to the binding specificity. The binding specificities of VLDLR and alpha2MR/LRP are overlapping, but not identical. The results suggest that VLDLR and alpha2MR/LRP have different biological functions by having different binding specificities as well as by being expressed by different cell types.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amyloid beta-Protein Precursor
  • Animals
  • COS Cells / metabolism
  • Carrier Proteins / metabolism
  • Cricetinae
  • Endocytosis
  • Humans
  • Kinetics
  • Low Density Lipoprotein Receptor-Related Protein-1
  • Plasminogen Activator Inhibitor 1 / metabolism
  • Protease Nexins
  • Receptors, Cell Surface
  • Receptors, Immunologic / genetics
  • Receptors, Immunologic / metabolism*
  • Receptors, LDL / genetics
  • Receptors, LDL / metabolism*
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Serine Endopeptidases / metabolism*
  • Serpin E2
  • Serpins / metabolism*
  • Substrate Specificity
  • Thrombin / metabolism
  • Urokinase-Type Plasminogen Activator / metabolism

Substances

  • Amyloid beta-Protein Precursor
  • Carrier Proteins
  • Low Density Lipoprotein Receptor-Related Protein-1
  • Plasminogen Activator Inhibitor 1
  • Protease Nexins
  • Receptors, Cell Surface
  • Receptors, Immunologic
  • Receptors, LDL
  • Recombinant Proteins
  • SERPINE2 protein, human
  • Serpin E2
  • Serpins
  • VLDL receptor
  • Serine Endopeptidases
  • Thrombin
  • Urokinase-Type Plasminogen Activator